![](/images/general/no_picture/200_user.png)
Christine T Mui
Examiner (ID: 15280, Phone: (571)270-3243 , Office: P/1797 )
Most Active Art Unit | 1797 |
Art Unit(s) | 1777, 1709, 1797, 1774 |
Total Applications | 1416 |
Issued Applications | 1043 |
Pending Applications | 77 |
Abandoned Applications | 296 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5827024
[patent_doc_number] => 20060062798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/515872
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5860
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515872
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515872 | Vaccines | May 22, 2003 | Abandoned |
Array
(
[id] => 6966495
[patent_doc_number] => 20050233392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Diagnosis of hepatocellular carcinoma'
[patent_app_type] => utility
[patent_app_number] => 10/514294
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8550
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514294 | Diagnosis of hepatocellular carcinoma | May 21, 2003 | Issued |
Array
(
[id] => 903701
[patent_doc_number] => 07335747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Cancer associated gene mina 53, protein Mina 53 and monoclonal antibody thereof'
[patent_app_type] => utility
[patent_app_number] => 10/509073
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 13
[patent_no_of_words] => 20071
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335747.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509073
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509073 | Cancer associated gene mina 53, protein Mina 53 and monoclonal antibody thereof | Apr 13, 2003 | Issued |
Array
(
[id] => 6977810
[patent_doc_number] => 20050287528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Methods for detecting ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 10/510321
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19874
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287528.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510321 | Methods for detecting ovarian cancer | Apr 3, 2003 | Abandoned |
Array
(
[id] => 151930
[patent_doc_number] => 07683159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-23
[patent_title] => 'Tenascin-W compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/509009
[patent_app_country] => US
[patent_app_date] => 2003-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13879
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/683/07683159.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509009
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509009 | Tenascin-W compositions and uses thereof | Mar 25, 2003 | Issued |
Array
(
[id] => 197124
[patent_doc_number] => 07638619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-29
[patent_title] => 'Variable region gene of heavy/light chain of anti-human hepatoma monoclonal antibody HAb 18 and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/507941
[patent_app_country] => US
[patent_app_date] => 2003-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6597
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/638/07638619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507941 | Variable region gene of heavy/light chain of anti-human hepatoma monoclonal antibody HAb 18 and use thereof | Mar 16, 2003 | Issued |
Array
(
[id] => 7103414
[patent_doc_number] => 20050106140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Antagonistic anti-hfas ligand human antibodies and fragments thereof'
[patent_app_type] => utility
[patent_app_number] => 10/506743
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12295
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506743
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506743 | Antagonistic anti-hFAS ligand human antibodies and fragments thereof | Mar 11, 2003 | Issued |
Array
(
[id] => 5648384
[patent_doc_number] => 20060134116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Ca 125 tumor antigen function and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/507728
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 13932
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134116.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507728
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507728 | Ca 125 tumor antigen function and uses thereof | Mar 10, 2003 | Abandoned |
Array
(
[id] => 7313269
[patent_doc_number] => 20040033542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer'
[patent_app_type] => new
[patent_app_number] => 10/376538
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14638
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033542.pdf
[firstpage_image] =>[orig_patent_app_number] => 10376538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/376538 | Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer | Feb 27, 2003 | Issued |
Array
(
[id] => 7362467
[patent_doc_number] => 20040005294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'IGFBP-3 in the diagnosis and treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/377142
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 44987
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005294.pdf
[firstpage_image] =>[orig_patent_app_number] => 10377142
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/377142 | IGFBP-3 in the diagnosis and treatment of cancer | Feb 24, 2003 | Abandoned |
Array
(
[id] => 856946
[patent_doc_number] => 07375206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Brother of the regulator of imprinted sites (BORIS)'
[patent_app_type] => utility
[patent_app_number] => 10/505377
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15229
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/375/07375206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505377
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505377 | Brother of the regulator of imprinted sites (BORIS) | Feb 20, 2003 | Issued |
Array
(
[id] => 5922155
[patent_doc_number] => 20060240417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Agent controlling the apoptosis induction by p73'
[patent_app_type] => utility
[patent_app_number] => 10/502449
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7699
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240417.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502449
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502449 | Agent controlling the apoptosis induction by p73 | Jan 22, 2003 | Abandoned |
Array
(
[id] => 5643217
[patent_doc_number] => 20060281672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin\'s disease, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/537839
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 23998
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537839 | Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof | Dec 5, 2002 | Abandoned |
Array
(
[id] => 8176776
[patent_doc_number] => 08178320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-15
[patent_title] => 'Artificial antibody library with super-repertory'
[patent_app_type] => utility
[patent_app_number] => 10/496349
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14723
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/178/08178320.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496349 | Artificial antibody library with super-repertory | Nov 21, 2002 | Issued |
Array
(
[id] => 7361795
[patent_doc_number] => 20040091475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Degraded tpo agonist antibody'
[patent_app_type] => new
[patent_app_number] => 10/399518
[patent_app_country] => US
[patent_app_date] => 2003-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 29291
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091475.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399518
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399518 | Degraded TPO agonist antibody | Oct 21, 2001 | Issued |
Array
(
[id] => 267238
[patent_doc_number] => 07566764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-28
[patent_title] => 'Truncated BARD1 protein, and its diagnostic and therapeutic uses'
[patent_app_type] => utility
[patent_app_number] => 10/363285
[patent_app_country] => US
[patent_app_date] => 2001-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 6199
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363285 | Truncated BARD1 protein, and its diagnostic and therapeutic uses | Sep 2, 2001 | Issued |
Array
(
[id] => 5952244
[patent_doc_number] => 20020007051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Use of multiple recombination sites with unique specificity in recombinational cloning'
[patent_app_type] => new
[patent_app_number] => 09/732914
[patent_app_country] => US
[patent_app_date] => 2000-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 83521
[patent_no_of_claims] => 142
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20020007051.pdf
[firstpage_image] =>[orig_patent_app_number] => 09732914
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/732914 | Use of multiple recombination sites with unique specificity in recombinational cloning | Dec 10, 2000 | Issued |